Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study

BACKGROUND: Clinical trials demonstrated that women treated for breast cancer with anthracycline or trastuzumab are at increased risk for heart failure and/or cardiomyopathy (HF/CM), but the generalizability of these findings is unknown. We estimated real-world adjuvant anthracycline and trastuzumab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bowles, Erin J. Aiello, Wellman, Robert, Feigelson, Heather Spencer, Onitilo, Adedayo A., Freedman, Andrew N., Delate, Thomas, Allen, Larry A., Nekhlyudov, Larissa, Goddard, Katrina A. B., Davis, Robert L., Habel, Laurel A., Yood, Marianne Ulcickas, Mccarty, Catherine, Magid, David J., Wagner, Edward H., Pharmacovigilance Study Team
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3433392/
https://ncbi.nlm.nih.gov/pubmed/22949432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djs317
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados